Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia
Full article: Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
27 Survival analysis | The Epidemiologist R Handbook
Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
Long-term survival and quality of life after intensive care for patients 80 years of age or older | Annals of Intensive Care | Full Text
Kaplan-Meier estimates of cumulative overall survival a | Open-i
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma | Haematologica
Cancers | Free Full-Text | Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study
27 Survival analysis | The Epidemiologist R Handbook
Introduction to Survival Data
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Survival Analysis in R
Survival Analysis in R
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice | European Journal of Nuclear Medicine and Molecular Imaging
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma | Radiation Oncology | Full Text
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
Overall survival from the date of progression.
Entropy | Free Full-Text | Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators
Overall survival curve for the “all taxa” data set (Kaplan-Meier estimate and corresponding 95% confidence intervals; N = 4447; the length of time axis is limited to a maximum of 15 days).
Understanding Survival Analyses | SpringerLink
